HolderBook

ACORN CAPITAL ADVISORS, LLC

Reported holdings as of Q2 2026, from 7 quarterly filings.

CIK
2054410
Reported value
$366.5M
Positions
20
Top 10 weight
90.2%
Filed
2026-08-14
Days after quarter end
45

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
CG ONCOLOGY INCCGON$80.4M1,131,50021.94%+0.17pp7qHELD
UROGEN PHARMA LTDURGN$61.6M1,673,42016.80%+8.25pp7qHELD
TREVI THERAPEUTICS INCTRVI$40.0M2,144,84410.92%+3.64pp7qHELD
CANDEL THERAPEUTICS INCCADL$36.0M3,497,9489.83%+4.94pp7qHELD
PUMA BIOTECHNOLOGY INCPBYI$33.5M4,131,2999.14%+1.64pp7qHELD
JADE BIOSCIENCES INCJBIO$21.9M986,7605.98%+2.84pp2q+25.4%+$4.4M
BICARA THERAPEUTICS INCBCAX$19.1M643,3815.21%+1.58pp7qHELD
KARYOPHARM THERAPEUTICS INCKPTI$14.8M1,518,1134.05%+3.59pp2q+427.4%+$12.0M
ONKURE THERAPEUTICS INCOKUR$12.9M2,839,6743.53%+0.19pp7qHELD
CYBIN INCHELP$10.2M1,540,2662.78%+0.68pp7qHELD
PROTARA THERAPEUTICS INCTARA$6.7M1,752,1151.83%-0.77pp7qHELD
AURA BIOSCIENCES INCAURA$6.6M929,0771.80%+0.67pp6q+56.0%+$2.4M
LEONABIO INCLONA$5.8M634,5391.59%-0.26pp3qHELD
VERASTEM INCVSTM$5.6M1,469,1531.53%-0.68pp7qHELD
WHITEHAWK THERAPEUTICS INCWHWK$5.2M1,139,3631.42%+0.31pp7qHELD
Q32 BIO INCQTTB$2.8M216,1710.75%+0.18pp7q-31.4%-$1.3M
Engene Therapeutics IncENGN$2.2M1,271,2570.60%-newNEW
JASPER THERAPEUTICS INCJSPR$604.0K1,438,1590.16%-0.19pp4q+1.9%+$11.2K
BIOATLA INCBCAB$447.6K108,1260.12%-0.12pp7q-98.0%-$21.9M
VYNE THERAPEUTICS INCVYNE$9261,4250.00%flat7qHELD

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 100.0%
 
SectorValueShare
Biotech & Pharma$366.5M100.0%
Not classified$9260.0%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2026$366.5M20142390.2%45
Q1 2026$351.8M22245188.9%45
Q4 2025$295.1M21143088.7%48
Q3 2025$197.0M20121287.7%48
Q2 2025$152.9M21075183.3%45
Q1 2025$149.9M22142080.4%49
Q4 2024$185.8M21000079.2%139

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.